For the study, the researchers reviewed 16 randomized controlled trials published in various journals that assessed the efficacy of using wearable biosensors, such as activity trackers, to improve select clinical outcomes. They evaluated the studies based on factors like sample size and confidence intervals.
The analysis revealed remote patient monitoring had no significant influence on the six clinical outcomes reported in the trials, which included body mass index, weight, waist circumference, body fat percentage, systolic blood pressure and diastolic blood pressure.
“We found substantial gaps in the evidence base that should be considered before implementation of remote patient monitoring in the clinical setting,” the study authors concluded. They added interventions that used personalized coaching were most successful in achieving clinical outcomes.
More articles on telehealth:
GlobalMed to provide telehealth services to DOD: 3 things to know
Teladoc releases integrated mobile app after Best Doctors acquisition
FCC proposes rule to lift $400M funding cap on rural telehealth program
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
